nach oben

Erschienen in:

01.09.2009 | Research

Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction

verfasst von: M Brehm, F Picard, P Ebner, G Turan, E Bölke, M Köstering, P Schüller, T Fleissner, D Ilousis, K Augusta, M Peiper, Ch Schannwell, BE Strauer

Erschienen in: European Journal of Medical Research | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of the present study was to determine whether regular exercise training (ET) is effective at promoting the mobilization of CPCs and improving their functional activity in patients with recently acquired myocardial infarction(STEMI). Regular physical training has been shown to improve myocardial perfusion and cardiovascular function. This mayberelatedin part to a mobilization of bonemarrow-derived circulating progenitor cells (CPCs) as well as an enhanced vascularisation.

Methods

37 patients with STEMI were randomly assigned to an ET group or a non-ET group(controls). Two weeks after STEMI, three weeks after regular ET and three months after ET, BNP levels, exercise echocardiography and exercise spiroergometry were evaluated. The number of CD34⁺/CD45⁺ and CD133⁺/CD45⁺CPCs was measured by flow cytometry analysis. The migration capacity of the CPCs was determined with a boyden chamber and the clonogenic capacity by CFU-assay.

Results

In the ET-group the number and migration capacity of CPCs increased significantly after regular exercise training. The BNP level decreased significantly from 121 ± 94 to 75 ± 47 pg/ml (p < 0.001) after the ET period, the left ventricular rejection fraction raised in parallel at peak exercise, and the cardiorespiratory condition improved as demonstrated by an increase of VO₂max (from 1641 ± 522 to 1842 ± 724 ml/min, p < 0.02). These three effects persist till three months after the ET period.

Conclusions

Regular physical activity appears to predispose the mobilization and enhanced functional activity of CPCs, a phenomenon which might lead to an improved cardiac function in patients with recently acquired acute myocardial infarction.

Morris JN, Everitt MG, Pollard R, Chave SP, Semmence AM: Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet 1980, 2: 1207–1210.PubMedCrossRef

Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh CC: Physical activity, all-cause mortality, and longevity of college alumni. N Eng J Med 1986, 314: 605–613. 10.1056/NEJM198603063141003CrossRef

Sesso HD, Paffenbarger RS, Lee I-M: Physical activitiy and coronary heart disease in men; the Harvard alumni health study. Circulation 2000, 102: 975–980.PubMedCrossRef

Paul D Thompson MD: Exercise prescription and proscription for patients with coronary artery disease. Circulation 2005, 112: 2354–2363. 10.1161/CIRCULATIONAHA.104.502591PubMedCrossRef

Sebrechts CP, Klein JL, Ahnve S, Froelicher VF, Ashburn VL: Myocardial perfusion changes following 1 year of exercise training assessed by thallium-201 circumferential count profiles. Am Heart J 1986, 112: 1217–1226. 10.1016/0002-8703(86)90351-0PubMedCrossRef

Heringlake M, Kox T, Poeling J, et al.: The effects of physical exercise on plasma levels of relaxin, NTpro ANP, and NTproBNP in patients with ischemic heart disease. Eur J Med Res 2009,14(3):106–112. 10.1186/2047-783X-14-3-106PubMedCentralPubMedCrossRef

Hambrecht R, Wolf A, Gielen S, et al.: Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Eng J Med 2000, 342: 454–460. 10.1056/NEJM200002173420702CrossRef

Aicher A, Heeschen C, Mildner-Rihm C, et al.: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003, 9: 1370–1376. 10.1038/nm948PubMedCrossRef

Takahashi T, Kalka C, Masuda H, et al.: Ischemia- and cytokine- induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5: 434–438. 10.1038/7434PubMedCrossRef

10.

Asahara T, Takahashi T, Masuda H: VEGF contributes to postnatal neovascularization by mobilizing bone-marrow endothelial progenitor cells. EMBO J 1999, 18: 3964–3972. 10.1093/emboj/18.14.3964PubMedCentralPubMedCrossRef

11.

Asahara T, Masuda H, Takahashi T, et al.: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85: 221–228.PubMedCrossRef

12.

Shintani S, Murohara T, Ikeda H, et al.: Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103: 2776–2779. 10.1161/hc2301.092122PubMedCrossRef

13.

Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, Estrov Z: Transdifferan-tiation of human peripheral blood CD34⁺ enriched cell population into cardiomyocytes, endothelial cells and smooth muscle cells in vivo. Circulation 2003, 108: 2070–2073. 10.1161/01.CIR.0000099501.52718.70PubMedCrossRef

14.

Vasa M, Fichtlscherer S, Aicher A, et al.: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89: E1–7. 10.1161/hh1301.093953PubMedCrossRef

15.

Volker A, Lenk K, Linke A, et al.: Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 2004, 24: 684–690. 10.1161/01.ATV.0000124104.23702.a0CrossRef

16.

Gysan DB, Heinzler R, Schmidt K: Primary results and long-term outcome of an ambulatory, cardiac rehabilitation model (phase II) after myocardial infarct, dilatation treatment and heart operation. Z Kardiol 1997, 86: 691–702. 10.1007/s003920050110PubMedCrossRef

17.

Schonstedt S, Beckmann S, Disselhoff W, Russmann B: Experiences with ambulatory cardiologic phase II rehabilitation. Herz 1999,24(Suppl 1):3–8.PubMedCrossRef

18.

Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: The ISHAGE guidelines for CD34⁺ cell determination by flow cytometry. J Hematotherapy 1996, 5: 213–226. 10.1089/scd.1.1996.5.213CrossRef

19.

Borowitz MJ, Guenther KL, Schults KE, Stelzer GT: Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 1993, 100: 534–540.PubMed

20.

Crosby JR, Kamiski WE, Schatteman G, et al.: Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000, 87: 728–730.PubMedCrossRef

21.

Isner JM, Asahara T: Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. Clin Invest 1999, 103: 1231–1236. 10.1172/JCI6889CrossRef

22.

Lin Y, Weisdorf DJ, Solovey A, Hebbel RP: Origins of circulating endothelial cells and endothelial outgrowth from blood. Eur J Clin Invest 2000, 278: H1042-H1048.

23.

Strauer BE, Brehm M, Zeus T, et al.: Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106: 1913–1918. 10.1161/01.CIR.0000034046.87607.1CPubMedCrossRef

24.

Meyer G, Wollert K, Drexler H: Stem cell therapy: a new perspective in the treatment of patients with acute myocardial infarction. Eur J Med Res 2006,11(10):439–46.PubMed

25.

Wollert KC, Meyer GP, Lotz J, et al.: Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364: 141–148. 10.1016/S0140-6736(04)16626-9PubMedCrossRef

26.

Schachinger V, Erbs S, Elsasser A, et al.: Inracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355: 1210–1221. 10.1056/NEJMoa060186PubMedCrossRef

27.

Assmus B, Honold J, Schachinger V, et al.: Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355: 1222–1232. 10.1056/NEJMoa051779PubMedCrossRef

28.

Luttun A, Carmeliet G, Carmeliet P: Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 2002, 12: 88–96. 10.1016/S1050-1738(01)00152-9PubMedCrossRef

29.

Fritzenwanger M, Lorenz F, Jung C, et al.: Differential number of CD34⁺ , CD133⁺ and CD34⁺ /CD133⁺ cells in peripheral blood of patients with congestive heart failure. Eur J Med Res 2009,14(3):113–117.PubMedCentralPubMed

30.

Yin AH, Miraglia S, Zanjani ED, et al.: AC133, a novel marker for human haematopoietic stem and progenitor cells. Blood 1997, 90: 5002–5012.PubMed

31.

Peichev M, Naiyer AJ, Pereira D, et al.: Expression of VEGFR-2 and AC133 by circulating human CD34⁺ cells identifies a population of functional endothelial precursors. Blood 2000, 95: 952–958.PubMed

32.

Yeh ETH, Zhang S, Wu HD, Körbling M, Willerson JT, Estrov Z: Transdifferentiation of human peripheral blood CD34⁺ enriched cell population into cardiomyocytes, endothelial cells and smooth muscle cells in vivo. Circulation 2003, 108: 2070–2073. 10.1161/01.CIR.0000099501.52718.70PubMedCrossRef

33.

Orlic D, Kajstura J, Chimenti S, et al.: Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410: 701–705. 10.1038/35070587PubMedCrossRef

34.

Orlic D, Kajstura J, Chimenti S, et al.: Mobilised bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001, 98: 10344–10349. 10.1073/pnas.181177898PubMedCentralPubMedCrossRef

35.

Kawamoto A, Gwon HC, Iwaguro H, et al.: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103: 634–637.PubMedCrossRef

36.

Kawamoto A, Tkebuchava T, Yamaguchi J, et al.: Intramyocardial transplanta-tion of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischaemia. Circulation 2003, 107: 461–468. 10.1161/01.CIR.0000046450.89986.50PubMedCrossRef

37.

Kocher AA, Schuster MD, Szabolcs MJ, et al.: Neovascularization of ischaemic myocardium by human bone marrow- derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7: 430–436. 10.1038/86498PubMedCrossRef

38.

Fuchs S, Baffour R, Zhou YF, et al.: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischaemia. J Am Coll Cardiol 2001, 37: 1726–1732. 10.1016/S0735-1097(01)01200-1PubMedCrossRef

39.

Vasa M, Fichtlsscherer S, Adler K, Aicher A, Zeiher A, Dimmeler S: Increase in circulating endothelial progenitor cells in patients by statin therapy in patients with stable coronary artery disease. Circulation 2001, 103: r21-r26.CrossRef

40.

Kalka C, Tehrani H, Laudenberg B, Vale PR, Isner JM, Asahara T, Symes JF: VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg 2000, 70: 829–834. 10.1016/S0003-4975(00)01633-7PubMedCrossRef

41.

Laufs U, Werner N, Link A, et al.: Physical training increases endothelial progenitor cell, inhibits neointima formation, and enhances angiogenesis. Circulation 2004, 109: 220–226. 10.1161/01.CIR.0000109141.48980.37PubMedCrossRef

42.

Heeschen C, Lehmann R, Honold J, et al.: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109: 1615–1622. 10.1161/01.CIR.0000124476.32871.E3PubMedCrossRef

43.

Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA: Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Eng J Med 2000, 342: 626–633. 10.1056/NEJM200003023420904CrossRef

44.

Pillarisetti K, Gupta SK: Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 2001, 25: 293–300. 10.1023/A:1012808525370PubMedCrossRef

45.

Yamaguchi J, Kusano KF, Masuo O, et al.: Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107: 1322–1328. 10.1161/01.CIR.0000055313.77510.22PubMedCrossRef

46.

Massa M, Rosti V, Ferrario M, et al.: Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005, 105: 199–206. 10.1182/blood-2004-05-1831PubMedCrossRef

47.

Tyni-Lenne R, Gordon A, Europe E, Jansson E, Sylven C: Exercise based rehabilitation improves skeletal muscle capacity, exercise tolerance, and quality of life in both women and men with chronic heart failure. J Card Fail 1998, 4: 9–17.PubMedCrossRef

48.

Smart N, Marwick TH: Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 2004, 116: 693–796. 10.1016/j.amjmed.2003.11.033PubMedCrossRef

49.

Cheetham C, Green D, Collis J, Dembo L, O'Driscoll G: Effect of aerobic and resistance exercise on central hemodynamic responses in severe chronic heart failure. J Appl Physiol 2002, 93: 175–180.PubMedCrossRef

50.

Pina IL, Apstein CS, Balady GJ, et al.: American Heart Association Committee on exercise, rehabilitation, and prevention. Exercise and heart failure: a statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention. Circulation 2003, 107: 1210–1225. 10.1161/01.CIR.0000055013.92097.40PubMedCrossRef

51.

Coats AJ, Adamopoulos S, Radaelli A, et al.: Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992, 85: 2119–2131.PubMedCrossRef

52.

Giannuzzi P, Temporelli PL, Corra U, Gattone M, Giordano A, Tavazzi L: Attenuation of unfavorable remodeling by exercise training in post infarction patients with left ventricular dysfunction. Results of the Exercise in Left Ventricu-lar Dysfunction (ELVD) Trial. Circulation 1997, 96: 1790 1797.PubMedCrossRef

53.

Schuler G, Hambrecht R, Schlierf G, Grunze M, Methfessel S, Hauer K, Kübler W: Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol 1992, 19: 34–42. 10.1016/0735-1097(92)90048-RPubMedCrossRef

54.

Barletta GA, Fattirolli F, Bisi G, et al.: Short term responses to cardiac rehabilitation after acute myocardial infarction. Cardiac function evaluation before and after physical training at rest and during stress test. Eur Heart J 1983, 4: 761 772.PubMed

55.

Dressendorfer RH, Franklin BA, Cameron JL, Trahan KJ, Gordon S, Timmis GC: Exercise training frequency in early postinfarction cardiac rehabilitation. Influence on aerobic conditioning. J Cardiopulm Rehabil 1995, 15: 269–276. 10.1097/00008483-199507000-00003PubMedCrossRef

56.

Ohtsuka M, Takano H, Zou Y, et al.: Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 2004, 18: 851–853.PubMed

57.

Ohki Y, Heissig B, Sato Y, et al.: Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005, 19: 2005–2007.PubMed

58.

Askari AT, Unzek S, Popovic ZB, et al.: Effect of stromalcell-derived factor 1 on stemcell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362: 697–703. 10.1016/S0140-6736(03)14232-8PubMedCrossRef

59.

Gunning MG, Walker J, Eastick S, Bomanji JB, Ell PJ, Walker JM: Exercise training following myocardial infarction improves myocardial perfusion assessed by thallium201 scintigraphy. Int J Cardiol 2002, 84: 233–239. 10.1016/S0167-5273(02)00145-6PubMedCrossRef

60.

Hung J, Gordon EP, Houston N, Haskell WL, Goris ML, DeBusk RF: Changes in rest and exercise myocardial per-fusion and left ventricular function 3 to 26 weeks after clinically uncomplicated acute myocardial infarction: effects of exercise training. Am J Cardiol 1984, 54: 943–950. 10.1016/S0002-9149(84)80123-XPubMedCrossRef

61.

Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW: Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem 2004, 264: 63–74.PubMedCrossRef

Titel: Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction
verfasst von: M Brehm
F Picard
P Ebner
G Turan
E Bölke
M Köstering
P Schüller
T Fleissner
D Ilousis
K Augusta
M Peiper
Ch Schannwell
BE Strauer
Publikationsdatum: 01.09.2009
Verlag: BioMed Central
Erschienen in: European Journal of Medical Research / Ausgabe 9/2009
Elektronische ISSN: 2047-783X
DOI: https://doi.org/10.1186/2047-783X-14-9-393

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction

Abstract

Background

Methods

Results

Conclusions

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2009

Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy

Gasperini syndrome as clinical manifestation of pontine demyelination

Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial